Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CF 602

Next Previous
Drug Profile

CF 602

Alternative Names: CF-602

Latest Information Update: 10 May 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Leiden University; National Institutes of Health (USA)
  • Developer Can-Fite BioPharma
  • Class Amides; Aminoquinolines; Anti-inflammatories; Cyclohexanes; Erectile dysfunction therapies; Quinolines; Small molecules; Vasodilators
  • Mechanism of Action Adenosine A3 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Erectile dysfunction
  • Discontinued Autoimmune disorders; Inflammation; Osteoarthritis

Most Recent Events

  • 06 May 2024 Can-Fite Biopharma receives a Notice of Allowance for an A3 adenosine receptor ligands for use in treatment of a sexual dysfunction in Europe
  • 30 Oct 2023 CF 602 is still in preclinical trials for Erectile dysfunction in Israel (PO)
  • 10 Apr 2023 9386044: No updates

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top